Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials
Crossref DOI link: https://doi.org/10.1007/s10198-014-0648-7
Published Online: 2014-11-20
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kahle-Wrobleski, Kristin
Fillit, Howard
Kurlander, Jonathan
Reed, Catherine
Belger, Mark
License valid from 2014-11-20